Editorials

Is it time to reduce the doxorubicin dosage in Hodgkin lymphoma therapy?

Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel; Blood Bank and Apheresis Unit, Rambam Health Care Campus, Haifa, Israel; The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa
Haematologica Early view Feb 26, 2026 https://doi.org/10.3324/haematol.2025.289210